Syqe Medical's Solution to Resolve the CNS Dose Impairment Tradeoff
 

Potent CNS therapies often suffer from a narrow therapeutic window, where effective doses are close to those that cause cognitive or psychoactive side effects. This forces patients and clinicians to compromise between efficacy and tolerability, limiting real-world use and outcomes.

Syqe’s precise, microgram-level delivery technology is designed to overcome this barrier by maintaining therapeutic benefit while minimizing impairment—enabling safer, more consistent, and more widely usable CNS treatments.